Journal article icon

Journal article

Update to the effectiveness and cost-effectiveness of a mindfulness training programme in schools compared with normal school provision (MYRIAD): study protocol for a randomised controlled trial

Abstract:
Background: MYRIAD (My Resilience in Adolescence) is a superiority, parallel group, cluster randomised controlled trial designed to examine the effectiveness and cost-effectiveness of a mindfulness training (MT) programme, compared with normal social and emotional learning (SEL) school provision to enhance mental health, social-emotional-behavioural functioning and well-being in adolescence. The original trial protocol was published in Trials (accessible at https://doi.org/10.1186/s13063-017-1917-4). This included recruitment in two cohorts, enabling the learning from the smaller first cohort to be incorporated in the second cohort. Here we describe final amendments to the study protocol and discuss their underlying rationale. // Methods: Four major changes were introduced into the study protocol: (1) there were changes in eligibility criteria, including a clearer operational definition to assess the degree of SEL implementation in schools, and also new criteria to avoid experimental contamination; (2) the number of schools and pupils that had to be recruited was increased based on what we learned in the first cohort; (3) some changes were made to the secondary outcome measures to improve their validity and ability to measure constructs of interest and to reduce the burden on school staff; and (4) the current Coronavirus Disease 2019 (SARS-CoV-2 or COVID-19) pandemic both influences and makes it difficult to interpret the 2-year follow-up primary endpoint results, so we changed our primary endpoint to 1-year follow-up. // Discussion: These changes to the study protocol were approved by the Trial Management Group, Trial Steering Committee and Data and Ethics Monitoring Committees and improved the enrolment of participants and quality of measures. Furthermore, the change in the primary endpoint will give a more reliable answer to our primary question because it was collected prior to the COVID-19 pandemic in both cohort 1 and cohort 2. Nevertheless, the longer 2-year follow-up data will still be acquired, although this time-point will be now framed as a second major investigation to answer some new important questions presented by the combination of the pandemic and our study design
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s13063-021-05213-9

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-5092-7643
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7084-1495
More by this author
Role:
Author
ORCID:
0000-0002-4579-0670
More by this author
Role:
Author
ORCID:
0000-0002-7304-2231
More by this author
Role:
Author
ORCID:
0000-0001-5295-4904


More from this funder
Funder identifier:
10.13039/100004440
Grant:
WT104908/Z/14/Z


Publisher:
BioMed Central
Journal:
Trials More from this journal
Volume:
22
Issue:
1
Pages:
254
Article number:
254
Publication date:
2021-04-07
DOI:
EISSN:
1745-6215
ISSN:
1745-6215


Language:
English
Keywords:
Pubs id:
1171555
Local pid:
pubs:1171555
Source identifiers:
W4206392772
Deposit date:
2026-02-16
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP